Gaziantep University
Gaziantep, Şehitkamil, 27000, Turkey (Türkiye)
NCT Number: NCT07353242
This study was designed as a pre-test-post-test randomized controlled experimental trial to determine the effects of buteyko breathing technique application on fatigue, exercise capacity, and asthma control in asthma patients.The study, planned as a randomized controlled experimental study, included a total of 90 participants.
The sample consisted of asthma patients who applied to the Chest Diseases outpatient clinic of Gaziantep University Application and Research Hospital, had been diagnosed with asthma within the last 6 months, did not have heart failure, did not have communication or perception problems, did not have walking disabilities, and were between 18-59 years old.Following random assignment, participants were divided into two groups of 45 participants each. The groups were: 1) Buteyko 2) Control
Looking for future studies?
Notify Me18 year–59 year
All sexes
Interventional
Not applicable
Gaziantep, Şehitkamil, 27000, Turkey (Türkiye)
Asthma is a chronic inflammatory airway disease that affects individuals of all ages and represents a major public health problem due to its high prevalence and substantial clinical, social, and economic burden. In addition to respiratory symptoms, fatigue and functional limitations are common yet often overlooked in individuals with asthma, significantly impairing daily life. Alongside pharmacological treatments, low-cost, safe, and easily applicable non-pharmacological approaches are gaining increasing importance in asthma management. One such approach is the Buteyko breathing technique, a non-pharmacological breathing retraining method aimed at reducing hyperventilation, improving breathing patterns, and alleviating asthma symptoms. However, evidence regarding the effects of the Buteyko breathing technique on fatigue, functional exercise capacity, and asthma control remains limited. Therefore, this study aims to evaluate the effects of the Buteyko breathing technique on fatigue levels, functional exercise capacity, and asthma control in patients with asthma.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This intervention is distinguished by its standardized delivery by an internationally certified Buteyko practitioner and its integration of key Buteyko components, including reduced breathing, controlled breath-holding, nasal breathing with mouth taping, and relaxation. It incorporates both seated and walking-based exercises, uses objective measures such as Control Pause and step counting, and includes a structured home-based practice with weekly follow-up over six weeks.
Time frame: 6 weeks
The Asthma Control Test (ACT) is a practical, patient-completed scale consisting of five questions, scored between 5 and 25 points, that assesses the level of asthma control; higher scores indicate better control.
Time frame: 6 weeks
The Chronic Obstructive Pulmonary Disease and Asthma Fatigue Scale (COPD) is a 12-item, five-point Likert-type scale that assesses fatigue in individuals with asthma and COPD; higher scores indicate higher fatigue levels.
University of Gaziantep
Other
"THE EFFECT OF BUTEIKO RESPIRATORY TECHNIQUE APPLIED TO ASTHMA PATIENTS ON FATIGUE, EXERCISE CAPACITY, AND ASTHMA CONTROL"
Acronym: Buteyko Breath
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07394127
Asthma, Asthma Chronic
Gümüşhane, Trabzon, Ordu, Giresun, Rize, Artvin, Gümüşhane, Turkey (Türkiye)
View Trial DetailsNCT01678222
Allergic Inflammation, Asthma
Research Triangle Park, North Carolina, United States
View Trial DetailsNCT03937804
Asthma, Bronchial Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial Details